Anything is possible. I do get the feeling sometimes that MM includes some "potential" possibilities though. She did say there would be a deal to fund the trials and that never came to be. Maybe she is hoping for FDA fast tracking rather than knowing this will be the case.
Good HIV lab results will put a different slant on things though - maybe enough to get some sort of deal. Biotechs are very hard to predict
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
